Home › Acute Myeloid Leukemia › New Jersey › Edison
Acute Myeloid Leukemia clinical trials in Edison, NJ
20 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
A Study of CRD3874-SI in People With Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi away
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- Saint Peter's University Hospital, New Brunswick · 3 mi away
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi away
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi away
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi away
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi away
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RecruitingPhase 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Study of Revumenib and Mezigdomide in People With Leukemia
RecruitingPhase 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi away
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi away
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RecruitingPhase 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi away
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA30 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Edison
- Breast Cancer68 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer20 studies
- Endometrial Cancer19 studies
- Urothelial (Transitional Cell) Carcinoma18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.